A revised version of the Seirei Swallowing Questionnaire for people with cognitive decline (Swallow-10).


Journal

The journal of medical investigation : JMI
ISSN: 1349-6867
Titre abrégé: J Med Invest
Pays: Japan
ID NLM: 9716841

Informations de publication

Date de publication:
2023
Historique:
medline: 12 5 2023
pubmed: 11 5 2023
entrez: 10 5 2023
Statut: ppublish

Résumé

The Seirei dysphagia screening questionnaire (namely, Seirei dsq) has been used to screen for oropharyngeal dysphagia (OD). Some of the questions in the questionnaire are difficult for people with cognitive decline to answer. We selected 10 items from the Seirei dsq that could be assessed by others, such as care workers (named Swallow-10). This study aims to verify the validity of the scoring method used in Swallow-10. The dataset used in this study was the one used in the development of Seirei dsq : 50 patients with cerebrovascular disease who were diagnosed with OD, 145 patients with cerebrovascular disease who did not have OD, and 170 healthy subjects. Among the answer choices, "A" for severe symptom, "B" for mild symptom and "C" for no symptom were scored with 4, 1 and 0 points respectively. Factor analysis extracted two factors : one related to pharyngeal function and another related to oral function. In addition, the Cronbach's alpha coefficient was 0.84. ROC analysis indicated that optimal cutoff value was 5 points, with a sensitivity of 90.0% and a specificity of 88.5%. These results suggest that Swallow-10 may be useful as an OD screening tool for subjects with cognitive decline J. Med. Invest. 70 : 231-235, February, 2023.

Identifiants

pubmed: 37164727
doi: 10.2152/jmi.70.231
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

231-235

Auteurs

Masanori Nakano (M)

Faculty of Health and Welfare, Tokushima Bunri Univercity, 180 Bouji Nishihama Yamasiro-cho, Tokushima-city, Tokushima 770-8504, Japan.

Chihiro Shinohara (C)

Faculty of Health and Welfare, Tokushima Bunri Univercity, 180 Bouji Nishihama Yamasiro-cho, Tokushima-city, Tokushima 770-8504, Japan.

Hiromi Nakae (H)

Faculty of Health and Welfare, Tokushima Bunri Univercity, 180 Bouji Nishihama Yamasiro-cho, Tokushima-city, Tokushima 770-8504, Japan.

Yuka Sogawa (Y)

Faculty of Health and Welfare, Tokushima Bunri Univercity, 180 Bouji Nishihama Yamasiro-cho, Tokushima-city, Tokushima 770-8504, Japan.

Masami Yoshioka (M)

Faculty of Health and Welfare, Tokushima Bunri Univercity, 180 Bouji Nishihama Yamasiro-cho, Tokushima-city, Tokushima 770-8504, Japan.

Keisuke Nishigawa (K)

Faculty of Health and Welfare, Tokushima Bunri Univercity, 180 Bouji Nishihama Yamasiro-cho, Tokushima-city, Tokushima 770-8504, Japan.

Ruri Okuma (R)

Department of Rehabilitation Medicine, Chofu Touzan Hospital, 2-32-17 Kojima-cho, Chofu-City, Tokyo 182-0026, Japan.

Ichiro Fujishima (I)

Department of Rehabilitation Medicine, Hamamatsu City Rehabilitation Hospital, 1-6-1 Wago-kita, Nakaku, Hamamatsu-City, Shizuoka 433-8511, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH